Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Aug, 2016 | Pages:
77 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)
The Europe IVD market is expected to reach over USD 15.5 billion by 2024 according to a new report by Grand View Research, Inc. This expected increase in the demand is ascribed to the presence of novel and promising technologies in clinical laboratories, such as the introduction of Troponin T test by Roche Diagnostics in May, 2011. Persistent research and development efforts made to introduce automation in laboratories that perform analytical testsare projected to propel the market growth over the forecast period. Clinical laboratory operations require automated analyzers to cope with the large test volumes,which enhance the overall operational workflow. It minimizes the need for dedicated operator training andnegates the risk of human errors. In addition, the rising demand for portable and handheld IVD devicesis one of the major factors pushing forward the growth of the market. The increasing prevalence of chronic diseases, such as diabetes, cancers, and cardiac dysfunctions and the rising geriatric population coupled with the rising awareness towards early diagnosis in low-income countries, such as Bulgaria, Finland, Malta, and Estoniaare the potential drivers of the Europe IVD market. Further key findings from the study suggest: In 2015, the reagents segment dominated the Europe IVD market due to its increasing number of applications in the companion diagnostics area and the introduction of disease specific kits, such as the XpertTB kit The IVD instruments market is anticipated to show lucrative growth due to the introduction of portable instruments, such as MinION Analyzer by Oxford Nanopore, and the availability of various platforms to performtarget sequence analysis, thereby driving the overall demand Germany is one of the largest segments in 2015 with a share of over 19% owing to the presence of a larger geriatric population base in this region and the amendment ofthe German lawfor the prevention of hospital-acquired infections UK is expected to be the fastest growing regionduring the forecast period.The rising demand for the point-of-care devices coupled with the government interventions to incorporate innovative, cost-effective solutions in the healthcare services are expected to drive the market growth during the forecast period. The hospital-based IVD testing segment held the largest share of over 45% in 2015. The highprocedure volumes in this segment, is one of the major reasons resulting inthehigh share and;hence, is anticipated to maintain its market position over the forecast period. The market players of the Europe IVD market include Alere, Inc., bioMerieux, Inc., Hologic, Inc. (Gen-Probe), Roche Diagnostics, Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation, Abbott Laboratories, Inc., Becton, Dickinson (BD) and Company, Inc., and Siemens Healthcare GmbH The presence of major IVD market players in Europe accelerates the penetration of the IVD products throughout the European Union. For instance, in September 2014, Roche Diagnostics launched the CE approved Cobas 6800/8800 systems, which offers IVD-based viral load monitoring withenhanced flexibility and automation.
Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data Sources Chapter 2. Executive Summary 2.1. Europe IVD Market- Industry Snapshot and Key Buying Criteria, 2015 Chapter 3. Europe IVD Industry Outlook 3.1. Europe IVD Market Segmentation 3.2. Europe IVD Market Size and Growth Outlook 3.3. Europe IVD Market Dynamics 3.3.1. Market Drivers Estimates 3.3.1.1. Substantial Increase in Geriatric Population in Europe 3.3.1.2. Considerable Prevalence of Chronic Diseases 3.3.1.3. Growing Need for Point-of-Care Facilities. 3.3.2. Market Restraint Estimates 3.3.2.1. Stringent regulatory policies 3.4. Market Estimates - Porter's 3.5. Europe IVD Market PESTEL Estimates, 2015 Chapter 4. Europe IVD Product Outlook 4.1. Europe IVD Market Share by Product, 2015 & 2024 4.2. Instruments 4.2.1. Instruments Market Estimates and Forecasts, 2013 - 2024 4.3. Reagents 4.3.1. Reagents Market Estimates and Forecasts, 2013 - 2024 4.4. Services 4.4.1. Services Market Estimates and Forecasts, 2013 - 2024 Chapter 5. Europe IVD Technique Outlook 5.1. Europe IVD Market Share by technique, 2015 & 2024 5.2. Immunology 5.2.1. Immunology Market Estimates and Forecasts, 2013 - 2024 5.3. Hematology 5.3.1. Hematology Market Estimates and Forecasts, 2013 - 2024 5.4. Clinical Chemistry 5.4.1. Clinical Chemistry Market Estimates and Forecasts, 2013 - 2024 5.5. Molecular Diagnostics 5.5.1. Molecular Diagnostics Market Estimates and Forecasts, 2013 - 2024 5.6. Coagulation 5.6.1. Coagulation Market Estimates and Forecasts, 2013 - 2024 5.7. Microbiology 5.7.1. Microbiology Market Estimates and Forecasts, 2013 - 2024 5.8. Other Clinical Instruments 5.8.1. Other Clinical Instruments Market Estimates and Forecasts, 2013 - 2024 Chapter 6. Europe IVD Application Outlook 6.1. Europe IVD Market Share by Application, 2015 & 2024 6.2. Infectious Diseases 6.2.1. Infectious Disease Market Estimates and Forecasts, 2013 - 2024 6.3. Diabetes 6.3.1. Diabetes Market Estimates and Forecasts, 2013 - 2024 6.4. Oncology/Cancer 6.4.1. Oncology/Cancer Market Estimates and Forecasts, 2013 - 2024 6.5. Cardiology 6.5.1. Cardiology Market Estimates and Forecasts, 2013 - 2024 6.6. Nephrology 6.6.1. Nephrology Market Estimates and Forecasts, 2013 - 2024 6.7. Autoimmune Diseases 6.7.1. Autoimmune Diseases Market Estimates and Forecasts, 2013 - 2024 6.8. Drug Testing 6.8.1. Drug Testing Market Estimates and Forecasts, 2013 - 2024 6.9. Others 6.9.1. Others Market Estimates and Forecasts, 2013 - 2024 Chapter 7. Europe IVD End-use Outlook 7.1. Europe IVD Market Share by End-use, 2015 & 2024 7.2. Hospitals 7.2.1. Hospitals Market Estimates and Forecasts, 2013 - 2024 7.3. Laboratory 7.3.1. Laboratory Market Estimates and Forecasts, 2013 - 2024 7.4. Home Care 7.4.1. Home Care Market Estimates and Forecasts, 2013 - 2024 7.5. Others 7.5.1. Others Market Estimates and Forecasts, 2013 - 2024 Chapter 8. Europe IVD Regional Outlook 8.1. Europe Market Share by Region, 2015 & 2024 8.2. Europe 8.3. Europe Market Estimates and Forecasts, by Product, 2013 - 2024 (USD Million) 8.3.1. UK Market Estimates and Forecasts 8.3.2. Germany Market Estimates and Forecasts 8.3.3. Switzerland Market Estimates and Forecasts 8.3.4. France Market Estimates and Forecasts 8.3.5. Spain Market Estimates and Forecasts 8.3.6. Italy Market Estimates and Forecasts 8.3.7. Belgium Market Estimates and Forecasts 8.3.8. Austria Market Estimates and Forecasts 8.3.9. Netherlands Market Estimates and Forecasts 8.3.10. Sweden Market Estimates and Forecasts 8.4. Europe Market Estimates and Forecasts, by Technique, 2013 - 2024 (USD Million) 8.4.1. UK Market Estimates and Forecasts 8.4.2. Germany Market Estimates and Forecasts 8.4.3. Switzerland Market Estimates and Forecasts 8.4.4. France Market Estimates and Forecasts 8.4.5. Spain Market Estimates and Forecasts 8.4.6. Italy Market Estimates and Forecasts 8.4.7. Belgium Market Estimates and Forecasts 8.4.8. Austria Market Estimates and Forecasts 8.4.9. Netherlands Market Estimates and Forecasts 8.4.10. Sweden Market Estimates and Forecasts 8.5. Europe Market Estimates and Forecasts, by Application, 2013 - 2024 (USD Million) 8.5.1. UK Market Estimates and Forecasts 8.5.2. Germany Market Estimates and Forecasts 8.5.3. Switzerland Market Estimates and Forecasts 8.5.4. France Market Estimates and Forecasts 8.5.5. Spain Market Estimates and Forecasts 8.5.6. Italy Market Estimates and Forecasts 8.5.7. Belgium Market Estimates and Forecasts 8.5.8. Austria Market Estimates and Forecasts 8.5.9. Netherlands Market Estimates and Forecasts 8.5.10. Sweden Market Estimates and Forecasts 8.6. Europe Market Estimates and Forecasts, by End-use, 2013 - 2024 (USD Million) 8.6.1. UK Market Estimates and Forecasts 8.6.2. Germany Market Estimates and Forecasts 8.6.3. Switzerland Market Estimates and Forecasts 8.6.4. France Market Estimates and Forecasts 8.6.5. Spain Market Estimates and Forecasts 8.6.6. Italy Market Estimates and Forecasts 8.6.7. Belgium Market Estimates and Forecasts 8.6.8. Austria Market Estimates and Forecasts 8.6.9. Netherlands Market Estimates and Forecasts 8.6.10. Sweden Market Estimates and Forecasts Chapter 9. Competitive Landscape 9.1. Becton, Dickinson and Company, Inc. 9.1.1. Company Overview 9.1.2. Financial Performance 9.1.3. Product Benchmarking 9.1.4. Strategic Initiatives 9.2. bioMerieux, Inc. 9.2.1. Company Overview 9.2.2. Financial Performance 9.2.3. Product Benchmarking 9.2.4. Strategic Initiatives 9.3. Abbott Laboratories, Inc. 9.3.1. Company Overview 9.3.2. Financial Performance 9.3.3. Product Benchmarking 9.3.4. Strategic Initiatives 9.4. Quidel Corporation 9.4.1. Company Overview 9.4.2. Financial Performance 9.4.3. Product Benchmarking 9.4.4. Strategic Initiatives 9.5. Alere, Inc. 9.5.1. Company Overview 9.5.2. Financial Performance 9.5.3. Product Benchmarking 9.5.4. Strategic Initiatives 9.6. OraSure Technologies 9.6.1. Company Overview 9.6.2. Financial Performance 9.6.3. Product Benchmarking 9.6.4. Strategic Initiatives 9.7. Hologic, Inc. (Gen Probe) 9.7.1. Company Overview 9.7.2. Financial Performance 9.7.3. Product Benchmarking 9.7.4. Strategic Initiatives 9.8. Cepheid, Inc. 9.8.1. Company Overview 9.8.2. Financial Performance 9.8.3. Product Benchmarking 9.8.4. Strategic Initiatives 9.9. Qiagen N.V. 9.9.1. Company Overview 9.9.2. Financial Performance 9.9.3. Product Benchmarking 9.9.4. Strategic Initiatives 9.10. Roche Diagnostics 9.10.1. Company Overview 9.10.2. Financial Performance 9.10.3. Product Benchmarking 9.10.4. Strategic Initiatives 9.11. Siemens Healthcare GmbH 9.11.1. Company Overview 9.11.2. Financial Performance 9.11.3. Product Benchmarking 9.11.4. Strategic Initiatives 9.12. Bio-Rad Laboratories, Inc. 9.12.1. Company Overview 9.12.2. Financial Performance 9.12.3. Product Benchmarking 9.12.4. Strategic Initiatives
List of Tables
TABLE 1 Europe IVD market, - Industry Summary & Critical Success Factors (CSFs) TABLE 2 Europe IVD market, by product, 2013 - 2024 (USD million) TABLE 3 Europe IVD market, by application, 2013 - 2024 (USD million) TABLE 4 Europe IVD market, by technique, 2013 - 2024 (USD million) TABLE 5 Europe IVD market, by end-use, 2013 - 2024 (USD million) TABLE 6 Europe IVD market, by region, 2013 - 2024 (USD million) TABLE 7 Europe IVD Market, - Key market driver analysis TABLE 8 Europe IVD Market, - Key market restraint analysis TABLE 9 Germany IVD market, by product, 2013 - 2024 (USD million) TABLE 10 Germany IVD market, by application, 2013 - 2024 (USD million) TABLE 11 Germany IVD market, by technique, 2013 - 2024 (USD million) TABLE 12 Germany IVD market, by end-use, 2013 - 2024 (USD million) TABLE 13 Germany IVD market, by region, 2013 - 2024 (USD million) TABLE 14 UK IVD market, by product, 2013 - 2024 (USD million) TABLE 15 UK IVD market, by application, 2013 - 2024 (USD million) TABLE 16 UK IVD market, by technique, 2013 - 2024 (USD million) TABLE 17 UK IVD market, by end-use, 2013 - 2024 (USD million) TABLE 18 UK IVD market, by region, 2013 - 2024 (USD million) TABLE 19 Switzerland IVD market, by product, 2013 - 2024 (USD million) TABLE 20 Switzerland IVD market, by application, 2013 - 2024 (USD million) TABLE 21 Switzerland IVD market, by technique, 2013 - 2024 (USD million) TABLE 22 Switzerland IVD market, by end-use, 2013 - 2024 (USD million) TABLE 23 Switzerland IVD market, by region, 2013 - 2024 (USD million) TABLE 24 France IVD market, by product, 2013 - 2024 (USD million) TABLE 25 France IVD market, by application, 2013 - 2024 (USD million) TABLE 26 France IVD market, by technique, 2013 - 2024 (USD million) TABLE 27 France IVD market, by end-use, 2013 - 2024 (USD million) TABLE 28 France IVD market, by region, 2013 - 2024 (USD million) TABLE 29 Spain IVD market, by product, 2013 - 2024 (USD million) TABLE 30 Spain IVD market, by application, 2013 - 2024 (USD million) TABLE 31 Spain IVD market, by technique, 2013 - 2024 (USD million) TABLE 32 Spain IVD market, by end-use, 2013 - 2024 (USD million) TABLE 33 Spain IVD market, by region, 2013 - 2024 (USD million) TABLE 34 Italy IVD market, by product, 2013 - 2024 (USD million) TABLE 35 Italy IVD market, by application, 2013 - 2024 (USD million) TABLE 36 Italy IVD market, by technique, 2013 - 2024 (USD million) TABLE 37 Italy IVD market, by end-use, 2013 - 2024 (USD million) TABLE 38 Italy IVD market, by region, 2013 - 2024 (USD million) TABLE 39 Belgium IVD market, by product, 2013 - 2024 (USD million) TABLE 40 Belgium IVD market, by application, 2013 - 2024 (USD million) TABLE 41 Belgium IVD market, by technique, 2013 - 2024 (USD million) TABLE 42 Belgium IVD market, by end-use, 2013 - 2024 (USD million) TABLE 43 Belgium IVD market, by region, 2013 - 2024 (USD million) TABLE 44 Austria IVD market, by product, 2013 - 2024 (USD million) TABLE 45 Austria IVD market, by application, 2013 - 2024 (USD million) TABLE 46 Austria IVD market, by technique, 2013 - 2024 (USD million) TABLE 47 Austria IVD market, by end-use, 2013 - 2024 (USD million) TABLE 48 Austria IVD market, by region, 2013 - 2024 (USD million) TABLE 49 Netherlands IVD market, by product, 2013 - 2024 (USD million) TABLE 50 Netherlands IVD market, by application, 2013 - 2024 (USD million) TABLE 51 Netherlands IVD market, by technique, 2013 - 2024 (USD million) TABLE 52 Netherlands IVD market, by end-use, 2013 - 2024 (USD million) TABLE 53 Netherlands IVD market, by region, 2013 - 2024 (USD million) TABLE 54 Sweden IVD market, by product, 2013 - 2024 (USD million) TABLE 55 Sweden IVD market, by application, 2013 - 2024 (USD million) TABLE 56 Sweden IVD market, by technique, 2013 - 2024 (USD million TABLE 57 Sweden IVD market, by end-use, 2013 - 2024 (USD million) TABLE 58 Sweden IVD market, by region, 2013 - 2024 (USD million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
